Pennsylvania’s Department of Health has released application rules for universities and hospitals in the state interested in researching medical marijuana.
The research permits are part of Phase 2 of Pennsylvania’s medical marijuana program rollout.
Cannabis’ classification as a Schedule 1 drug has prevented much in the way of serious scientific study of the plant and its effects on consumers.
Research into cannabis could help to educate both the public and physicians, which in turn could lead to better opportunities for marijuana companies.
Here’s what you need to know:
- Drexel University, Penn Medicine and the University of the Sciences have expressed interest in adding marijuana research to their programs.
- In 2016, Thomas Jefferson University in Philadelphia announced a Center for Medical Cannabis Education & Research to study medical cannabis and educate doctors about recommending MMJ to patients.
- Also in 2016, the University of Pittsburgh Medical School expressed interest in collaborating with medical marijuana businesses to research MMJ.
- The Pennsylvania health department told NBC 10 there is no limit to how many research facilities could be permitted under Phase 2.